220 related articles for article (PubMed ID: 15312814)
1. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression.
Mannelli P; Gottheil E; Peoples JF; Oropeza VC; Van Bockstaele EJ
Biol Psychiatry; 2004 Aug; 56(4):261-8. PubMed ID: 15312814
[TBL] [Abstract][Full Text] [Related]
2. Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats.
Van Bockstaele EJ; Rudoy C; Mannelli P; Oropeza V; Qian Y
J Neurosci Res; 2006 Feb; 83(3):508-14. PubMed ID: 16385558
[TBL] [Abstract][Full Text] [Related]
3. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Holtzman SG
J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
[TBL] [Abstract][Full Text] [Related]
6. Electroacupuncture attenuates morphine withdrawal signs and c-Fos expression in the central nucleus of the amygdala in freely moving rats.
Liu S; Zhou W; Liu H; Yang G; Zhao W
Brain Res; 2005 May; 1044(2):155-63. PubMed ID: 15885214
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
[TBL] [Abstract][Full Text] [Related]
8. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
Jones KL; Barr GA
Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
[TBL] [Abstract][Full Text] [Related]
9. Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain.
Van Bockstaele EJ; Qian Y; Sterling RC; Page ME
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1048-56. PubMed ID: 18367303
[TBL] [Abstract][Full Text] [Related]
10. Antagonist treatment of opioid withdrawal translational low dose approach.
Mannelli P; Gottheil E; Van Bockstaele EJ
J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
[TBL] [Abstract][Full Text] [Related]
11. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
[TBL] [Abstract][Full Text] [Related]
12. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
13. Role of PKC-alpha,gamma isoforms in regulation of c-Fos and TH expression after naloxone-induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Marín MT; Milanés MV
J Neurochem; 2005 Dec; 95(5):1249-58. PubMed ID: 16190878
[TBL] [Abstract][Full Text] [Related]
14. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
Nye HE; Nestler EJ
Mol Pharmacol; 1996 Apr; 49(4):636-45. PubMed ID: 8609891
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
Panchal V; Taraschenko OD; Maisonneuve IM; Glick SD
Eur J Pharmacol; 2005 Nov; 525(1-3):98-104. PubMed ID: 16289028
[TBL] [Abstract][Full Text] [Related]
16. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cAMP response element-binding protein by lentiviral vector-mediated RNAi attenuates morphine withdrawal syndromes in rats.
Wu Q; Cao M; Wang T; Jiang P; Zhou K
Behav Brain Res; 2012 Jul; 233(1):217-23. PubMed ID: 22580231
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
Almela P; Victoria Milanés M; Luisa Laorden M
Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
[TBL] [Abstract][Full Text] [Related]
19. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
Druhan JP; Walters CL; Aston-Jones G
J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cell type-specific ablation of the cAMP-responsive transcription factor in noradrenergic neurons on locus coeruleus firing and withdrawal behavior after chronic exposure to morphine.
Parlato R; Cruz H; Otto C; Murtra P; Parkitna JR; Martin M; Bura SA; Begus-Nahrmann Y; von Bohlen und Halbach O; Maldonado R; Schütz G; Lüscher C
J Neurochem; 2010 Nov; 115(3):563-73. PubMed ID: 20367754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
